Global Metastatic Melanoma Therapeutics Market Anticipates Robust Growth with New Therapeutic Developments
27 mars 2024 15h46 HE
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Melanoma Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Market Growth and...
Capecitabine Global Market Report 2024
06 mars 2024 04h09 HE
|
Research and Markets
Dublin, March 06, 2024 (GLOBE NEWSWIRE) -- The "Capecitabine Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The capecitabine market size is expected to see...
Nivolumab Market Forecasts Indicate Robust Growth Driven by Advances in Cancer Immunotherapy and Increased Global Access to Care
15 févr. 2024 14h57 HE
|
Research and Markets
Dublin, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The "Nivolumab Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Recent advancements in cancer treatment and the...
Global Melanoma Therapeutics Market Set for Remarkable Growth, Projected to Reach $6.16 Billion by 2028
08 févr. 2024 11h37 HE
|
Research and Markets
Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Melanoma Therapeutics Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The global melanoma therapeutics market is...
Global Basal Cell Carcinoma Treatment Market Poised for Significant Growth, Forecasted Expansion at a CAGR of 8.12% from 2024-2034
01 févr. 2024 09h29 HE
|
Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Basal Cell Carcinoma Treatment Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The...
MTG201 + Nivolumab Drug and Market Analysis 2023-2032: Sales Analytics, Clinical Assessment, SWOT Analysis, Emerging Competitors
30 janv. 2024 10h50 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "MTG201 + nivolumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides...
Analysis of INOVIO's INO-5401 & INO-9012 and Regeneron & Sanofi's LIBTAYO (Cemiplimab) Treatment for Glioblastoma Multiforme (GBM): Drug Insights, Regulatory Landscape, and Market Forecast to 2032
30 janv. 2024 07h29 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "INO-5401 + INO-9012 + LIBTAYO Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This...
Global Actinic Keratosis Treatment Market Analysis, Share, Growth, Trends and Forecast to 2031, Featuring Sun Pharmaceutical, Biofrontera, Nestle, Novartis, GlaxoSmithKline, Almirall & LEO Pharma
26 janv. 2024 04h12 HE
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Actinic Keratosis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Melanoma Drugs - $13.98 Billion Industry Opportunity Assessment, 2024-2028: Regional Insights and Competitor Market Shares
24 janv. 2024 13h39 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Melanoma Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global melanoma drugs market has grown...
Capecitabine Market Research Reveals Significant Growth in Oncology Treatment Sector
09 janv. 2024 18h48 HE
|
Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Capecitabine Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The latest market research on capecitabine, a...